![](/img/cover-not-exists.png)
PAR4 ETANERCEPT VERSUS INFLIXIMAB PLUS METHOTREXATE IN RHEUMATOID ARTHRITIS: A COST-EFFECTIVENESS ANALYSIS FROM THE ITALIAN NHS PERSPECTIVE
S Lopatriello, P BertoVolume:
6
Year:
2003
Language:
english
DOI:
10.1016/s1098-3015(10)61849-9
File:
PDF, 66 KB
english, 2003